22.418 articles found

Effects of levodopa on striatal monoamines in mice with levodopa-induced hyperactivity.

Nicholas AP, Buck K, Ferger B.

Neurosci Lett · 2008-07-19

DOI: 10.1016/j.neulet.2008.07.039PMID: 18657593

Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.

Mann A, Miksys S, Lee A, Mash DC, Tyndale RF.

Neuropharmacology · 2008-07-19

DOI: 10.1016/j.neuropharm.2008.07.017PMID: 18687346

2, 3-DIHYDROBENZO[1, 4] DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES

DIN BELLE DAVID, HOLM PATRIK, KARLJALAINEN ARTO, TOLVANEN ARTO, WOHLFAHRT GERD, RUMMAKKO PETTERI.

· 2008-07-18

Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.

Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, Gironell A, García-Sánchez C, Martínez-Corral M.

Eur J Neurol · 2008-07-14

DOI: 10.1111/j.1468-1331.2008.02218.xPMID: 18637826

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.

Fleckenstein AE, Volz TJ, Hanson GR.

Neuropharmacology · 2008-07-10

DOI: 10.1016/j.neuropharm.2008.07.002PMID: 18662707

Medicinal composition containing levodopa and benserazide hydrochloride

ZHENG YUAN.

· 2008-07-09

TREATMENTS FOR ANY AND ALL MENTAL/BRAIN NEURON/SPINAL CORD ILLNESS

VOON GERARD.

· 2008-07-07

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING SIDE EFFECTS OF LEVODOPA WHICH IS AN AGENT FOR TREATING PARKINSON'S DISEASE

KOH JUNG MIN.

· 2008-07-04

Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Bortolato M, Chen K, Shih JC.

Adv Drug Deliv Rev · 2008-07-04

DOI: 10.1016/j.addr.2008.06.002PMID: 18652859

Use of vanillyl alcohol for the treatment of Parkinson's disease

HSU LUN-CHUNG, WEN ZHI-HONG, LEE KUAN-YU.

· 2008-07-03

LEVODOPA PRODRUG MESYLATE, COMPOSITIONS THEREOF, AND USES THEREOF

XIANG JIA NING, DAI XUEDONG, ZHOU CINDY X, LI JIANHUA, NGUYEN MARK Q.

· 2008-07-03

Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.

Palmer SJ, Eigenraam L, Hoque T, McCaig RG, Troiano A, McKeown MJ.

Neuroscience · 2008-07-03

DOI: 10.1016/j.neuroscience.2008.06.053PMID: 18722512